RAPP

RAPPORT THERAPEUTICS INC

RAPP·75383L102·US·Common Stock·Healthcare - Biotechnology-Activist

RAPP (RAPPORT THERAPEUTICS INC) is held by 91 institutional investors as of Q1 2026. Largest holders: FMR LLC ($224.3M), Capital International Investors ($96.9M), GOLDMAN SACHS GROUP INC ($92.1M). Net institutional sentiment: Mixed.

91
Holders
Avg rating(18 Elite)
$916M
Total Value
62% (100)
Fund Consensus
55 buying - 34 selling
RAPPSmart Money Verdict
View all
Held by 91 funds
18 elite
Who's Trading
InsiderTLThird Rock Ventures V, L.P.Sell $744KMay 26, 2026
ActivistCACormorant Asset Management, LP6.2%May 15, 2026
InsiderTLThird Rock Ventures V, L.P.Sell $202KMay 8, 2026
InsiderTLThird Rock Ventures V, L.P.Sell $10.9MMay 7, 2026
InsiderTLThird Rock Ventures V, L.P.Sell $17.2MApr 17, 2026
InsiderYKYeleswaram KrishnaswamySell $809KApr 17, 2026
InsiderYKYeleswaram KrishnaswamySell $358KApr 14, 2026
InsiderYKYeleswaram KrishnaswamySell $321KApr 13, 2026
InsiderYKYeleswaram KrishnaswamySell $17KApr 10, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.0%Jan 21, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.2M(+0.8%)$224.3M0.0%+100.70%
31
Decreased
3.1M(-8.9%)$96.9M0.0%+71.34%
0
Decreased
2.9M(-2.0%)$92.1M0.0%+69.82%
0
Increased
2.5M(+3.0%)$78.4M0.0%+83.56%
31
Increased
1.6M(+63.5%)$51.4M0.2%+48.95%
51
Unchanged
1.5M$48.4M0.3%+89.01%
0
New
1.3M$41.5M0.0%+49.91%
40
Decreased
918,866(-3.5%)$28.8M0.0%+76.84%
0
Decreased
866,456(-1.7%)$27.1M0.0%+114.42%
0
Increased
759,552(+6.3%)$23.8M0.0%+71.13%
30
Increased
721,622(+3.9%)$22.6M0.0%+77.05%
30
Decreased
727,843(-7.7%)$22.1M0.0%+84.48%
0
New
536,607$16.8M0.0%+49.91%
39
New
320,909$10M0.0%+49.91%
38
Increased
319,552(+58.3%)$10M0.0%+47.40%
40
Decreased
239,917(-1.8%)$7.5M0.0%+67.16%
0
Increased
237,992(+7.8%)$7.4M0.0%+80.86%
30
Increased
224,498(+168.9%)$7M0.0%+45.20%
44
Unchanged
194,200$6.1M0.0%+315.42%
0
New
189,253$5.9M0.0%+49.91%
38

Showing 1-20 of 100

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used